Intranasal Administration as a Route for Drug Delivery to the Brain: Evidence for a Unique Pathway for Albumin

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Journal of Pharmacology and Experimental Therapeutics

• Publication date

  2014-10-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1124/jpet.114.216705PMID 25027317PMCID PMC4165023
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Intranasal administration of oxytocin: Behavioral and clinical effects, a review

  2013cited by this paper
• Brain-wide pathway for waste clearance captured by contrast-enhanced MRI.

  2013cited by this paper
• Protein kinase C pharmacology: refining the toolbox.

  2013cited by this paper
• Intranasal leptin reduces appetite and induces weight loss in rats with diet-induced obesity (DIO).

  2012cited by this paper
• Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial.

  2012cited by this paper
• Intranasal delivery of biologics to the central nervous system.

  2012cited by this paper
• Intranasal administration of PACAP: uptake by brain and regional brain targeting with cyclodextrins.

  2012cited by this paper
• A Paravascular Pathway Facilitates CSF Flow Through the Brain Parenchyma and the Clearance of Interstitial Solutes, Including Amyloid β

  2012cited by this paper
• Impact of albumin on drug delivery--new applications on the horizon.

  2012influential reference
• Clinical impact of serum proteins on drug delivery.

  2012cited by this paper
• Intranasal Insulin Therapy for Alzheimer Disease and Amnestic Mild Cognitive Impairment A Pilot Clinical Trial

  2011cited by this paper
• Verapamil Block of T-Type Calcium Channels

  2011cited by this paper
• Intranasal insulin as a therapeutic option in the treatment of cognitive impairments.

  2011cited by this paper
• Brain delivery of proteins by the intranasal route of administration: a comparison of cationic liposomes versus aqueous solution formulations.

  2010cited by this paper
• Intranasal delivery to the central nervous system: mechanisms and experimental considerations.

  2010cited by this paper
• Delivery of testosterone to the brain by intranasal administration: Comparison to intravenous testosterone

  2009cited by this paper
• Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles.

  2008cited by this paper
• Effects of clonidine on lidocaine-induced inhibition of axonal transport in cultured mouse dorsal root ganglion neurones.

  2008cited by this paper
• Intranasal Insulin Administration Dose-Dependently Modulates Verbal Memory and Plasma Amyloid-β in Memory-Impaired Older Adults

  2008cited by this paper
• Evaluation of Direct Transport Pathways of Glycine Receptor Antagonists and an Angiotensin Antagonist from the Nasal Cavity to the Central Nervous System in the Rat Model

  2008cited by this paper
• Brain Endothelial Cell-Cell Junctions: How to “Open” the Blood Brain Barrier

  2008cited by this paper
• Effects of leptin on memory processing.

  2006cited by this paper
• The formation of molecular clouds in spiral galaxies

  2006cited by this paper
• Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration.

  2004cited by this paper
• Tyrosine phosphatase inhibition induces loss of blood-brain barrier integrity by matrix metalloproteinase-dependent and -independent pathways.

  2004cited by this paper
• Brain Uptake of the Glucagon-Like Peptide-1 Antagonist Exendin(9-39) after Intranasal Administration

  2004cited by this paper
• The phosphatidylinositol 4‐kinase inhibitor phenylarsine oxide blocks evoked neurotransmitter release by reducing calcium entry through N‐type calcium channels

  2000cited by this paper
• P-Glycoprotein, a gatekeeper in the blood-brain barrier.

  1999cited by this paper
• An Essential Role for a Small Synaptic Vesicle-Associated Phosphatidylinositol 4-Kinase in Neurotransmitter Release

  1998cited by this paper
• The synthesis and cellular roles of phosphatidylinositol 4,5-bisphosphate.

  1998cited by this paper
• Gp60 Activation Mediates Albumin Transcytosis in Endothelial Cells by Tyrosine Kinase-dependent Pathway*

  1997cited by this paper
• Effects of the obese gene product on body weight regulation in ob/ob mice.

  1995cited by this paper
• Filipin-sensitive caveolae-mediated transport in endothelium: reduced transcytosis, scavenger endocytosis, and capillary permeability of select macromolecules

  1994influential reference
• Blood to Brain and Brain to Blood Passage of Native Horseradish Peroxidase, Wheat Germ Agglutinin, and Albumin: Pharmacokinetic and Morphological Assessments

  1994cited by this paper
• Effect of endocytosis inhibitors on alveolar clearance of albumin, immunoglobulin G, and SP-A in rabbits.

  1994cited by this paper
• gp60 is an albumin-binding glycoprotein expressed by continuous endothelium involved in albumin transcytosis.

  1992influential reference
• Angiotensin Peptide Regulation of Fluid-Phase Endocytosis in Brain Microvessel Endothelial Cell Monolayers

  1990cited by this paper
• Mechanisms of the inhibition of fast axonal transport by local anesthetics.

  1989cited by this paper
• Absence of albumin receptor on brain capillaries in vivo or in vitro.

  1985cited by this paper
• Rapid, reversible internalization of cell surface insulin receptors. Correlation with insulin-induced down-regulation.

  1983cited by this paper
• REGIONAL STUDIES OF CATECHOLAMINES IN THE RAT BRAIN‐I

  1966influential reference
• THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY.

  1963cited by this paper

• Molecular insights, challenges and progressions of polysaccharide and protein-based biopolymeric carriers for intranasal drug delivery: A review.

  2026cites this paper
• Intranasal delivery of therapeutics to degenerating brain regions: From pathways to nanocarriers

  2026cites this paper
• Framework Nucleic Acid Nanomaterials for Central Nervous System Therapies: Design for Barrier Penetration, Targeted Delivery, Cellular Uptake, and Endosomal Escape.

  2025cites this paper
• The Nasal–Brain Drug Delivery Route: Mechanisms and Applications to Central Nervous System Diseases

  2025cites this paper
• Comparison of the hot-plate pain effect between three inhalation methods and subcutaneous injection of heroin.

  2025cites this paper
• SARS-CoV-2 spike protein causes synaptic dysfunction and p-tau and α-synuclein aggregation leading cognitive impairment: The protective role of metformin

  2025cites this paper
• Advanced intranasal peptide delivery systems for improved management of Alzheimer's disease.

  2025cites this paper
• Intranasal resveratrol delivery to the brain with chitosan-decorated bovine serum albumin nanoparticles: Advancing Alzheimer's management in old female rats through QbD-based optimization, in vitro evaluation, and in vivo exploration.

  2025cites this paper
• Intranasal drug delivery Dynamics: Extracellular and intracellular pathways revealed by Fluoro-Gold tracer in a mouse model.

  2025cites this paper
• Low-Intensity Ultrasound Facilitation of Intranasal Drug Delivery to Olfactory Bulb and Trigeminal Nerves.

  2025cites this paper
• Exposure to Airborne Particulate Matter and Undernutrition in Young Rats: An In-Depth Histopathological and Biochemical Study on Lung and Excretory Organs.

  2025cites this paper
• Albumin antagonizes Alzheimer's disease-related Tau pathology and enhances cognitive performance by inhibiting aberrant Tau aggregation.

  2025cites this paper
• The treatment of drug-induced rhinitis with an original intranasal combination: Efficacy and safety in experimental animals

  2025cites this paper
• Nose to Brain: Exploring the Progress of Intranasal Delivery of Solid Lipid Nanoparticles and Nanostructured Lipid Carriers

  2024cites this paper
• Bovine serum albumin nanoparticles: a promising platform for nasal drug delivery

  2024cites this paper
• A narrative review on potential applications of spanlastics for nose-to-brain delivery of therapeutically active agents.

  2024cites this paper
• Serum Albumin in Nasal Drug Delivery Systems: Exploring the Role and Application

  2024influential citation
• Intranasal delivery of glucagon-like peptide-1 to the brain for obesity treatment: opportunities and challenges

  2024cites this paper
• Intranasal drug delivery: The interaction between nanoparticles and the nose-to-brain pathway.

  2024cites this paper
• Comparative pharmacokinetic and intracerebral distribution of MDMB-4F-BICA in mice following inhalation ('vapor') and subcutaneous injection.

  2024cites this paper
• Local Delivery Strategies for Peptides and Proteins into the CNS: Status Quo, Challenges, and Future Perspectives

  2023cites this paper
• Intranasal GHK peptide enhances resilience to cognitive decline in aging mice

  2023cites this paper
• Nose-to-Brain (N2B) Delivery: An Alternative Route for the Delivery of Biologics in the Management and Treatment of Central Nervous System Disorders

  2023cites this paper
• Social defeat stress enhances the rewarding effects of cocaine through α1A adrenoceptors in the medial prefrontal cortex of mice.

  2023cites this paper
• Intranasal nanoparticulate delivery systems for neurodegenerative disorders: a review.

  2023cites this paper
• Nucleic acid-based therapeutics for the treatment of central nervous system disorders

  2023cites this paper
• Recent advances in nanotechnology for Intra-nasal drug delivery and clinical applications

  2023cites this paper
• The Upper Nasal Space: Option for Systemic Drug Delivery, Mucosal Vaccines and “Nose-to-Brain”

  2023cites this paper
• Intranasal Microemulsion as an Innovative and Promising Alternative to the Oral Route in Improving Stiripentol Brain Targeting

  2023cites this paper
• Development of early diagnosis of Parkinson's disease on animal models based on the intranasal administration of α-methyl-p-tyrosine methyl ester in a gel system.

  2022cites this paper
• Nose-to-brain drug delivery for the treatment of Alzheimer’s disease: current advancements and challenges

  2022cites this paper
• The nose has it: Opportunities and challenges for intranasal drug administration for neurologic conditions including seizure clusters

  2022cites this paper
• Evaluation of Recent Intranasal Drug Delivery Systems to the Central Nervous System

  2022cites this paper
• Intranasal drug delivery: opportunities and toxicologic challenges during drug development

  2021cites this paper
• FORMULATION DEVELOPMENT AND EVALUATION OF BRAIN TARGETED ESLICARBAMAZEPINE ACETATE NANOSUSPENSION FOR EPILEPSY

  2021cites this paper
• Drug Delivery Challenges in Brain Disorders across the Blood–Brain Barrier: Novel Methods and Future Considerations for Improved Therapy

  2021cites this paper
• Quantitative analysis of inulin distribution in the brain focused on nose-to-brain route via olfactory epithelium by reverse esophageal cannulation.

  2021cites this paper
• Development of In Situ Gelling Meloxicam-Human Serum Albumin Nanoparticle Formulation for Nose-to-Brain Application

  2021cites this paper
• Intranasal drug delivery for treatment of Alzheimer’s disease

  2021cites this paper
• Targeting Beclin1 as an Adjunctive Therapy against HIV Using Mannosylated Polyethylenimine Nanoparticles

  2021cites this paper
• NOSE-TO-BRAIN DRUG DELIVERY: AN UPDATE TO THE ALTERNATIVE PATH TO SUCCESSFUL TARGETED ANTI-MIGRAINE DRUGS

  2021cites this paper
• Intranasal fosphenytoin: the promise of phosphate esters in nose-to-brain delivery of poorly soluble drugs.

  2020cites this paper
• Development of Meloxicam-Human Serum Albumin Nanoparticles for Nose-to-Brain Delivery via Application of a Quality by Design Approach

  2020cites this paper
• Chaperone-Based Therapeutic Target Innovation: Heat Shock Protein 70 (HSP70) for Type 2 Diabetes Mellitus

  2020influential citation
• A Computational Systems Approach to Rational Design of Nose-to-Brain Delivery of Biopharmaceutics

  2020cites this paper
• DMSO_A_232133 559..568

  2020influential citation
• MicroRNA-206 Regulates Stress-Provoked Aggressive Behaviors in Post-weaning Social Isolation Mice

  2020cites this paper
• Intranasal delivery of Thyroid hormones in MCT8 deficiency

  2020influential citation
• Characterization of focused ultrasound-mediated brainstem delivery of intranasally administered agents.

  2020cites this paper
• Extracellular Vesicles as a Neprilysin Delivery System Memory Improvement in Alzheimer’s Disease

  2020cites this paper
• Outcomes and clinical implications of intranasal insulin administration to the central nervous system.

  2019cites this paper
• Current Limitations in the Treatment of Parkinson's and Alzheimer's Diseases: State-of-the-Art and Future Perspective of Polymeric Carriers.

  2019cites this paper
• Mitochondria-Targeted Nanoparticles

  2019cites this paper
• In Vivo Brain Delivery and Brain Deposition of Proteins with Various Sizes.

  2019cites this paper
• Strategies to facilitate or block nose-to-brain drug delivery.

  2019cites this paper
• Pharmacokinetics of Systemic Drug Delivery

  2019cites this paper
• Therapeutic Potential of Intranasal Drug Delivery in Preclinical Studies of Ischemic Stroke and Intracerebral Hemorrhage

  2019cites this paper
• Therapeutic Intranasal Delivery for Stroke and Neurological Disorders

  2019cites this paper
• Nasal administration of gonadotropin releasing hormone (GnRH) elicits sperm production in Fowler’s toads (Anaxyrus fowleri)

  2019cites this paper
• The Major Human Stress Protein Hsp 70 as a Factor of Protein Homeostasis and a Cytokine-Like Regulator

  2019cites this paper
• The Major Human Stress Protein Hsp70 as a Factor of Protein Homeostasis and a Cytokine-Like Regulator

  2019cites this paper
• Intranasal Erythropoietin Protects CA1 Hippocampal Cells, Modulated by Specific Time Pattern Molecular Changes After Ischemic Damage in Rats

  2019cites this paper
• [The Major Human Stress Protein Hsp70 as a Factor of Protein Homeostasis and a Cytokine-Like Regulator].

  2019cites this paper
• Intranasal Leptin Relieves Sleep‐disordered Breathing in Mice with Diet‐induced Obesity

  2019cites this paper
• In situ gel of lamotrigine for augmented brain delivery: development characterization and pharmacokinetic evaluation

  2019cites this paper
• Intranasal Administration of Hsp70: Molecular and Therapeutic Consequences

  2018cites this paper
• Intranasal delivery of a Fas-blocking peptide attenuates Fas-mediated apoptosis in brain ischemia

  2018cites this paper
• Nanotherapeutics: An insight into healthcare and multi-dimensional applications in medical sector of the modern world.

  2018cites this paper
• Odor Sensitivity After Intranasal Insulin Application Is Modulated by Gender

  2018cites this paper
• Mechanism of intranasal drug delivery directly to the brain

  2018influential citation
• Role of serum albumin as a nanoparticulate carrier for nose‐to‐brain delivery of R‐flurbiprofen: implications for the treatment of Alzheimer's disease

  2018cites this paper
• Alfalfa-derived HSP70 administered intranasally improves insulin sensitivity in mice

  2017cites this paper
• Passage through the Ocular Barriers and Beneficial Effects in Retinal Ischemia of Topical Application of PACAP1-38 in Rodents

  2017cites this paper
• Intranasal delivery of N‐terminal modified leptin‐pluronic conjugate for treatment of obesity

  2017cites this paper
• Nose-to-brain peptide delivery - The potential of nanotechnology.

  2017cites this paper
• Intranasal Insulin Transport is Preserved in Aged SAMP8 Mice and is Altered by Albumin and Insulin Receptor Inhibition

  2017cites this paper
• Nanotherapeutics_ An insight into healthcare and multi-dimensional applications in medical sector of the modern world

  2017cites this paper
• Nanotechnology Applications for Diffuse Intrinsic Pontine Glioma

  2016cites this paper
• Ocular Delivery of PACAP1-27 Protects the Retina From Ischemic Damage in Rodents.

  2016cites this paper
• Factors influencing the fabrication of albumin-bound drug nanoparticles (ABDns): Part II. Albumin-bound carbamazepine nanoparticles (ABCns)

  2016influential citation
• Intranasal administration of elastin-like polypeptide for therapeutic delivery to the central nervous system

  2016cites this paper
• Novel Protein Delivery Platforms to Modulate SDF-1α/CXCR4 Signaling in the Adult Cortex

  2016cites this paper
• Role of functionalized liposomes in drug delivery through the blood-brain barrier

  2016cites this paper
• The role of neonatal immunity in preterm brain injury

  2016cites this paper
• Intranasal guanosine administration presents a wide therapeutic time window to reduce brain damage induced by permanent ischemia in rats

  2015cites this paper
• Central Nervous System Delivery of Intranasal Insulin: Mechanisms of Uptake and Effects on Cognition

  2015cites this paper
• The meninges: new therapeutic targets for multiple sclerosis.

  2015cites this paper
• Intranasal Delivery of Proteins and Peptides in the Treatment of Neurodegenerative Diseases

  2015cites this paper
• The Fate of Exogenous Human HSP70 Introduced into Animal Cells by Different Means.

  2015cites this paper
• Challenges and new strategies for therapeutic peptide delivery to the CNS.

  2015cites this paper